IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 204 filers reported holding IMMUNOGEN INC in Q4 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3 | -99.9% | 631 | 0.0% | 0.00% | – |
| Q3 2022 | $3,000 | +50.0% | 631 | +39.3% | 0.00% | – |
| Q2 2022 | $2,000 | -66.7% | 453 | -68.7% | 0.00% | – |
| Q1 2022 | $6,000 | -33.3% | 1,446 | +15.3% | 0.00% | – |
| Q4 2021 | $9,000 | +350.0% | 1,254 | +151.8% | 0.00% | – |
| Q3 2021 | $2,000 | -50.0% | 498 | -25.2% | 0.00% | – |
| Q2 2021 | $4,000 | -20.0% | 666 | +5.5% | 0.00% | – |
| Q1 2021 | $5,000 | +150.0% | 631 | +66.9% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 378 | -5.3% | 0.00% | – |
| Q3 2020 | $1,000 | -50.0% | 399 | -0.7% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 402 | +1.5% | 0.00% | – |
| Q1 2020 | $1,000 | -75.0% | 396 | -49.3% | 0.00% | – |
| Q4 2019 | $4,000 | +100.0% | 781 | -12.2% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 890 | -10.2% | 0.00% | – |
| Q2 2019 | $2,000 | -87.5% | 991 | -82.9% | 0.00% | – |
| Q1 2019 | $16,000 | – | 5,808 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,984,734 | $15,421,000 | 1.00% |
| Moloney Securities Asset Management, LLC | 274,450 | $1,062,000 | 0.55% |
| Schonfeld Strategic Advisors LLC | 1,025,176 | $3,968,000 | 0.40% |
| Orbimed Advisors | 6,095,647 | $23,590,000 | 0.27% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $438,000 | 0.26% |
| PINNACLE ASSOCIATES LTD | 1,589,959 | $6,153,000 | 0.12% |
| Baker Brothers Advisors | 3,015,353 | $11,669,000 | 0.10% |
| BAXTER BROS INC | 58,000 | $224,000 | 0.07% |
| SIMON QUICK ADVISORS, LLC | 25,000 | $97,000 | 0.06% |
| ClearBridge Investments | 14,428,856 | $55,840,000 | 0.06% |